Cargando…

DEC2 Serves as Potential Tumor Suppressor in Breast Carcinoma

BACKGROUND: Identification of new biomarkers can facilitate the development of effective therapeutic strategies in breast cancer (BC). Data from previous studies have revealed that differentiated embryonic chondrocyte gene (DEC) 1 and DEC2 might involve in the progression of various cancer types. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Wentong, Li, Qian, Wang, Min, Zheng, Mingjie, Xu, Huirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569433/
https://www.ncbi.nlm.nih.gov/pubmed/33101542
http://dx.doi.org/10.1155/2020/6053154

Ejemplares similares